Item 7.01. Regulation FD Disclosure.

Yesterday, Walmart Inc. ("Walmart") issued a press release regarding a lawsuit against the U.S. Department of Justice and the U.S. Drug Enforcement Administration, asking a federal court to clarify the roles and responsibilities of pharmacists and pharmacies under the Controlled Substances Act. A copy of the press release is furnished as Exhibit 99.1 to this report.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liability of that section and shall not be incorporated by reference into any filing or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document.




Item 9.01. Financial Statements and Exhibits.
(d)  Exhibits
         Press Release dated October 22, 2020 issued by Walmart Inc. related to a
99.1   litigation matter.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses